Literature DB >> 19012693

Plasma nitric oxide, endothelin-1, arginase and superoxide dismutase in pre-eclamptic women.

Fabiana Bernardi1, Larissa Constantino, Roberta Machado, Fabricia Petronilho, Felipe Dal-Pizzol.   

Abstract

AIM: The aim of this study was to determine several parameters of nitric oxide metabolism in pre-eclamptic patients.
METHODS: We conducted a nested case-control study at the Department of Obstetrics and Gynecology, São José Hospital, Brazil. Thirty-five pre-eclamptic and 35 normotensive pregnant women were included in the study. Pre-eclampsia was diagnosed as an increase in diastolic blood pressure (BP) of 15 mm Hg and systolic BP of 30 mm Hg at two measurements at least 4 h apart, compared with BP obtained before 20 weeks of gestation, and proteinuria > 0.3 g/24 h in the absence of urinary tract infection. Fasting peripheral venous blood samples were obtained during the antepartum period in pre-eclamptic and control (matched for maternal age and gestational age) patients.
RESULTS: Plasma nitrite was significantly lower and plasma endothelin levels were significantly higher in pre-eclamptic women than in normotensive pregnant women. Superoxide dismutase activity was decreased and arginase activity was significantly increased in pre-eclamptic patients when compared to normotensive pregnant women.
CONCLUSIONS: We suggested that in pre-eclampsia excessive arginase and low superoxide dismutase activity leads to a decrease nitric oxide levels and oxidative stress, and this may promote microvascular oxidative damage and endothelial dysfunction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19012693     DOI: 10.1111/j.1447-0756.2008.00860.x

Source DB:  PubMed          Journal:  J Obstet Gynaecol Res        ISSN: 1341-8076            Impact factor:   1.730


  23 in total

1.  Recent insights into the pathophysiology of preeclampsia.

Authors:  Eric M George; Joey P Granger
Journal:  Expert Rev Obstet Gynecol       Date:  2010-09-01

Review 2.  The emerging role of endothelin-1 in the pathogenesis of pre-eclampsia.

Authors:  Langeza Saleh; Koen Verdonk; Willy Visser; Anton H van den Meiracker; A H Jan Danser
Journal:  Ther Adv Cardiovasc Dis       Date:  2016-01-10

3.  Autoantibody-mediated IL-6-dependent endothelin-1 elevation underlies pathogenesis in a mouse model of preeclampsia.

Authors:  Cissy Chenyi Zhou; Roxanna A Irani; Yingbo Dai; Sean C Blackwell; M John Hicks; Susan M Ramin; Rodney E Kellems; Yang Xia
Journal:  J Immunol       Date:  2011-04-11       Impact factor: 5.422

Review 4.  Nitric Oxide and Hydrogen Sulfide Regulation of Ischemic Vascular Growth and Remodeling.

Authors:  Saranya Rajendran; Xinggui Shen; John Glawe; Gopi K Kolluru; Christopher G Kevil
Journal:  Compr Physiol       Date:  2019-06-12       Impact factor: 9.090

Review 5.  Arginases and arginine deficiency syndromes.

Authors:  Sidney M Morris
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2012-01       Impact factor: 4.294

Review 6.  Mechanisms and potential therapies for preeclampsia.

Authors:  Eric M George; Joey P Granger
Journal:  Curr Hypertens Rep       Date:  2011-08       Impact factor: 5.369

7.  Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injury.

Authors:  Patricia Redecha; Nico van Rooijen; Donald Torry; Guillermina Girardi
Journal:  Blood       Date:  2009-02-20       Impact factor: 22.113

8.  Endothelial nitric oxide synthase gene G894T polymorphism and risk assessment for pregnancy-induced hypertension: evidence from 11 700 subjects.

Authors:  Qiong Ma; Jianmin Lv; Kuikui Huang; Huaqi Guo; Wenliang Yang; Wen Luo; Jie Qiu; Lan Yang
Journal:  Hypertens Res       Date:  2016-07-28       Impact factor: 3.872

Review 9.  Preeclampsia: Updates in Pathogenesis, Definitions, and Guidelines.

Authors:  Elizabeth Phipps; Devika Prasanna; Wunnie Brima; Belinda Jim
Journal:  Clin J Am Soc Nephrol       Date:  2016-04-19       Impact factor: 8.237

Review 10.  Role of endothelin in uteroplacental circulation and fetal vascular function.

Authors:  Alexandra Paradis; Lubo Zhang
Journal:  Curr Vasc Pharmacol       Date:  2013-09       Impact factor: 2.719

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.